Akorn Pharmaceuticals

Akorn Investor Relations

SEC Filings

Filing date Form Description Filing Group View
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

3,4,5
SC 13D/A

An amendment to a SC 13D filing

3,4,5
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
8-K

Report of unscheduled material events or corporate event

Current Reports
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
10-Q/A

Amendment to a previously filed 10-Q

Quarterly Filings
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
8-K/A

Amendment to a previously filed 8-K

Current Reports